Merck KGa A officials say that, ultimately, the SMARTfacturing transformation benefits its customers, patients, and the ...

Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

Immunovant will use results from its Phase III myasthenia gravis study to support pipeline candidate IMVT-1402 over the trial ...

Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions: Our Bureau, Bengaluru Thursday, March 20, 2025, 14:15 Hrs [IST] Syngene International ...

In the closing of the recent trading day, Merck (MRK) stood at $94.02, denoting a -0.74% change from the preceding trading day.

IntroductionProgrammed cell death protein 1 (PD-1) and its ligand, PD-L1, are crucial immune checkpoints that regulate the ...

Oncology Small Molecule Drugs Market Expected to Grow Significantly Due to Industry Advancements. Growing Demand for Personalized Medicine and Targeted Therapies to Boost Small Molecule Drugs, States ...

The Adeno Associated Virus Vector Manufacturing market, valued at USD 1,148.4 million in 2024, is expected to register robust revenue CAGR of 19.6%.Request free copy of this report:  March 14, 2025 - ...

PORTLAND, OR, UNITED STATES, March 20, 2025 /EINPresswire / -- The global skin cancer treatment market has exp ...

Merck’s stock price slipped 0.74% to $94.02, lagging behind the broader market’s gains. This dip came despite Merck ...